Perceptions of pregnant women on COVID-19 and COVID-19 vaccine associated risks

Author:

Meer Sara1,Thomas Dixon1,Sebastian Juny2,Gopakumar Aji3,McKeirnan Kimberly3

Affiliation:

1. College of Pharmacy, Gulf Medical University, Ajman, UAE.

2. Data and Statistics/Healthcare/EHS, Dubai, UAE.

3. College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, USA.

Abstract

Introduction: COVID-19 impacted the health and life of many people affecting certain special populations more than others. The main objective of this study was to analyze the perception of pregnant women in the UAE on COVID-19 infection, COVID-19 vaccination, harassment, discrimination, and health risks. Materials & Methods: The study design was exploratory cross-sectional research. A Google Form survey was created and circulated to pregnant or recently pregnant women in the United Arab Emirates. The survey elements were harassment, discrimination, and health risks perceived by pregnant women related to their pregnancy and COVID-19 infection. Alpha value was set at 0.05. SPSS version 26 (Armonk, NY) was used for data analysis. Results: A total of 117 pregnant women completed the survey. Among the 117, 63% of the pregnant women were fully vaccinated with at least two doses of COVID-19 vaccination. Less of the fully vaccinated pregnant women contracted COVID-19 while being pregnant (p-value <0.05). Pregnant women who contracted COVID-19 had a statistically significant increase (p-value <0.05)in their perceived harassment, discrimination and risk to health/welfare. More of these negative factors were on the fully vaccinated but still contracted with COVID-19 group and least with fully vaccinated who did not contract COVID-19 when they were pregnant. Conclusions: Perceptions of pregnant women on COVID-19 and COVID-19 vaccines showed concerns that needs to be studied further. Perceived health issues related to the infection and vaccine need multifaceted interventions.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference44 articles.

1. Coronavirus disease (COVID-19). 2022 Mar 15. Available from https://www.who.int/health-topics/coronavirus#tab=tab_1(accessed on 15 June 2022).

2. Questions and Answers: COVID-19 vaccines and pregnancy. 2022 Feb 15 [cited 2022 Jun 6] Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-FAQ-Pregnancy-Vaccines-2022.1 accessed on 15 June 2022).

3. COVID-19 Vaccine. 2022 May 22 [cited 2022 Jun 6]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines (accessed on 15 June 2022).

4. Allotey J. Stallings E. Bonet M. Yap M. Chatterjee S. Kew T. Debenham L. Llavall AC. Dixit A. Zhou D and Balaji R. Clinical manifestations. risk factors. and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370:m3320. doi: 10.1136/bmj.m3320.

5. Wei SQ. Bilodeau-Bertrand M. Liu S and Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021; 193(16):E540-E548.doi: 10.1503/cmaj.202604.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3